Julie Sawyer Montgomery serves as Executive Vice President and Group President of Biotechnology at Danaher Corporation, a global science and technology innovator. With over two decades of leadership experience, she joined Danaher in 2004 following the company's acquisition of Sybron Chemicals, where she had built a strong foundation in industrial operations and business development. Her early career at Danaher included pivotal roles such as President of ChemTreat, Inc., a leader in water treatment solutions, where she drove significant revenue growth, expanded market share, and championed operational excellence through the Danaher Business System. Montgomery's ascent within Danaher reflects her strategic vision and execution prowess. She progressed to lead Danaher's Environmental & Applied Solutions segment before assuming her current biotechnology responsibilities in 2020. Under her stewardship, the Biotechnology Group—encompassing Beckman Coulter Life Sciences, Integrated DNA Technologies, and Leica Microsystems—has accelerated innovation in genomics, proteomics, and cellular analysis, delivering breakthrough technologies that advance life sciences research and diagnostics. Her achievements include fostering a culture of continuous improvement, executing key acquisitions, and achieving double-digit growth amid complex market dynamics. Recognized as a transformative leader, Montgomery is committed to diversity, inclusion, and sustainability, earning accolades such as being named one of the Most Influential Corporate Directors by the National Association of Corporate Directors. At Danaher, she plays a critical role in shaping the company's portfolio strategy, leveraging her expertise to propel biotechnology advancements that address global health challenges and drive shareholder value.